Weiss Multi-Strategy Advisers’s Xenon Pharmaceuticals XENE Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-5,000
| Closed | -$230K | – | 450 |
|
|
2023
Q4 | $230K | Buy |
+5,000
| New | +$230K | 0.01% | 455 |
|
|
2023
Q2 | – | Sell |
-54,140
| Closed | -$1.94M | – | 719 |
|
|
2023
Q1 | $1.94M | Buy |
+54,140
| New | +$1.94M | 0.05% | 402 |
|
|
2017
Q3 | – | Sell |
-31,500
| Closed | -$99K | – | 567 |
|
|
2017
Q2 | $99K | Hold |
31,500
| – | – | ﹤0.01% | 432 |
|
|
2017
Q1 | $126K | Hold |
31,500
| – | – | 0.01% | 443 |
|
|
2016
Q4 | $243K | Hold |
31,500
| – | – | 0.01% | 324 |
|
|
2016
Q3 | $255K | Sell |
31,500
-900
| -3% | -$7.29K | 0.02% | 319 |
|
|
2016
Q2 | $191K | Sell |
32,400
-18,600
| -36% | -$110K | 0.01% | 331 |
|
|
2016
Q1 | $356K | Buy |
51,000
+6,000
| +13% | +$41.9K | 0.02% | 354 |
|
|
2015
Q4 | $362K | Buy |
45,000
+2,600
| +6% | +$20.9K | 0.02% | 275 |
|
|
2015
Q3 | $350K | Buy |
+42,400
| New | +$350K | 0.02% | 298 |
|